about
Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesityTransgenerational inheritance of prenatal obesogen exposure.Minireview: PPARγ as the target of obesogens.Endocrine disrupting chemicals and disease susceptibility.RIPPLY3 is a retinoic acid-inducible repressor required for setting the borders of the pre-placodal ectodermBisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARγ).Obesogens: an emerging threat to public health.Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease.On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens.Reply to "Comment on 'On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens'".Transcriptional and epigenetic mechanisms underlying enhanced in vitro adipocyte differentiation by the brominated flame retardant BDE-47.Retinoic acid signaling and neuronal differentiation.RARβ2 is required for vertebrate somitogenesis.ERF and ETV3L are retinoic acid-inducible repressors required for primary neurogenesis.The unexpected teratogenicity of RXR antagonist UVI3003 via activation of PPARγ in Xenopus tropicalis.RARγ is required for mesodermal gene expression prior to gastrulation in XenopusReplyEnvironmental Chemicals and ObesityAdipocytes as Target Cells for Endocrine DisruptionZnf703 is a novel RA target in the neural plate border.
P50
Q28307782-10F2A058-5C06-47A5-BDE8-73FAD95C23BFQ34674521-17702201-C26D-43E5-9081-E46C0DB7B46BQ35050699-E1A6A951-4F7C-4F86-A777-C4E99FDEFBF3Q35563441-249F945B-F2C9-41E6-930B-96635C348363Q35768103-A59BF0D7-5CD5-4A67-A514-A14254A05E78Q36115466-1EE2C2B0-B21D-4349-BD79-CE6ACEAE4724Q36543144-03A347D5-A222-4935-9671-304902DBAEBFQ36853195-0C7681DA-D05B-4758-A37A-4D91BFD8539CQ36946543-BF55DC2C-6722-4FC4-A872-414FDB6B09C3Q37158812-3B41F6B4-B0C5-4229-8EAC-9CAE3C8A546AQ37578044-C1E3257F-934D-4516-AAD2-D5640B4823A6Q37697325-9E2491A5-D652-456A-926F-61ED08C03962Q38307264-0E61FBC3-0B51-4875-82B6-D2458A68A204Q44270685-820FE52F-D964-47FB-8BC6-D3D83B614353Q46012931-4B80A7E5-C2AB-4C2D-88FC-6D7D78E4A6D2Q46107408-AE0C8F3E-59F5-4C18-AAFD-3656E08C4FECQ59770057-A00EB68D-643F-4BFD-AF37-A61E8628C8E6Q59969883-34210E32-6485-4D5D-A945-2C6BD6EDC4E3Q59969940-A80C1E00-E19B-44D0-BC4B-B09F67B18839Q59969969-2DBD1D55-5342-4722-B22F-E1E51E74EC1CQ64928091-0E403FFE-9143-4C53-95FD-C3BE44A494E1
P50
description
US medical researcher (head/neck surgery)
@en
wetenschapper
@nl
name
Amanda Janesick
@ast
Amanda Janesick
@en
Amanda Janesick
@es
Amanda Janesick
@nl
type
label
Amanda Janesick
@ast
Amanda Janesick
@en
Amanda Janesick
@es
Amanda Janesick
@nl
prefLabel
Amanda Janesick
@ast
Amanda Janesick
@en
Amanda Janesick
@es
Amanda Janesick
@nl
P106
P2038
Amanda_Janesick
P21
P31
P496
0000-0001-7731-2756